These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24404903)

  • 41. Plasma sodium and subclinical left atrial enlargement in chronic kidney disease.
    Yee-Moon Wang A; Lu Y; Cheung S; Hiu-Shuen Chan I; Wai-Kei Lam C
    Nephrol Dial Transplant; 2013 Sep; 28(9):2319-28. PubMed ID: 23314317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myocardial dysfunction occurs prior to changes in ventricular geometry in mice with chronic kidney disease (CKD).
    Winterberg PD; Jiang R; Maxwell JT; Wang B; Wagner MB
    Physiol Rep; 2016 Mar; 4(5):. PubMed ID: 26997631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular disease in children with chronic kidney disease.
    Mitsnefes MM
    Adv Chronic Kidney Dis; 2005 Oct; 12(4):397-405. PubMed ID: 16198279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Heart effect of arterial hypertension. Heart hypertrophy as a risk factor. Study technics (electrocardiogram, echocardiography, exercise test and Holter].
    Aguilera Saldaña MA; García Moreno LM; Rodríguez Padial L; Navarro Lima A; Sánchez Domínguez J
    Rev Esp Cardiol; 1990; 43 Suppl 1():54-64. PubMed ID: 2139976
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview.
    Vasan RS; Levy D
    Arch Intern Med; 1996 Sep; 156(16):1789-96. PubMed ID: 8790072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac size, autonomic function, and 5-year follow-up of chronic heart failure patients with severe prolongation of ventricular activation.
    Kearney MT; Zaman A; Eckberg DL; Lee AJ; Fox KA; Shah AM; Prescott RJ; Shell WE; Charuvastra E; Callahan TS; Brooksby WP; Wright DJ; Gall NP; Nolan J
    J Card Fail; 2003 Apr; 9(2):93-9. PubMed ID: 12751129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Anemia in chronic kidney disease and its cardiovascular implications].
    Cases A; Coll E; Collado S
    Med Clin (Barc); 2009 May; 132 Suppl 1():38-42. PubMed ID: 19460479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kidney disease and cardiovascular risk.
    Tonelli M; Pfeffer MA
    Annu Rev Med; 2007; 58():123-39. PubMed ID: 17081079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What happens to the heart in chronic kidney disease?
    Rutherford E; Mark PB
    J R Coll Physicians Edinb; 2017 Mar; 47(1):76-82. PubMed ID: 28569289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies.
    Hamed SA
    Expert Rev Clin Pharmacol; 2019 Jan; 12(1):61-90. PubMed ID: 30501441
    [No Abstract]   [Full Text] [Related]  

  • 51. Early inflammatory changes and CC chemokine ligand-8 upregulation in the heart contribute to uremic cardiomyopathy.
    Amador-Martínez I; García-Ballhaus J; Buelna-Chontal M; Cortés-González C; Massó F; Jaisser F; Barrera-Chimal J
    FASEB J; 2021 Aug; 35(8):e21761. PubMed ID: 34245616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic kidney disease and cardiovascular complications.
    Di Lullo L; House A; Gorini A; Santoboni A; Russo D; Ronco C
    Heart Fail Rev; 2015 May; 20(3):259-72. PubMed ID: 25344016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mapping cardiac remodeling in chronic kidney disease.
    Kaesler N; Cheng M; Nagai J; O'Sullivan J; Peisker F; Bindels EMJ; Babler A; Moellmann J; Droste P; Franciosa G; Dugourd A; Saez-Rodriguez J; Neuss S; Lehrke M; Boor P; Goettsch C; Olsen JV; Speer T; Lu TS; Lim K; Floege J; Denby L; Costa I; Kramann R
    Sci Adv; 2023 Nov; 9(47):eadj4846. PubMed ID: 38000021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A systematic review and meta-analysis of murine models of uremic cardiomyopathy.
    Soppert J; Frisch J; Wirth J; Hemmers C; Boor P; Kramann R; Vondenhoff S; Moellmann J; Lehrke M; Hohl M; van der Vorst EPC; Werner C; Speer T; Maack C; Marx N; Jankowski J; Roma LP; Noels H
    Kidney Int; 2022 Feb; 101(2):256-273. PubMed ID: 34774555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of echocardiographic study in patients with chronic kidney disease.
    Liu YW; Su CT; Song EJ; Tsai WC; Li YH; Tsai LM; Chen JH; Sung JM
    J Formos Med Assoc; 2015 Sep; 114(9):797-805. PubMed ID: 26188763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miRNAs in Uremic Cardiomyopathy: A Comprehensive Review.
    D'Agostino M; Mauro D; Zicarelli M; Carullo N; Greco M; Andreucci M; Coppolino G; Bolignano D
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sarcopenia or uremic myopathy in CKD patients].
    Chauveau P; Moreau K; Lasseur C; Fouque D; Combe C; Aparicio M
    Nephrol Ther; 2016 Apr; 12(2):71-5. PubMed ID: 26598033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uremic cardiomyopathy: role of circulating digitalis like substances.
    Mohmand B; Malhotra DK; Shapiro JI
    Front Biosci; 2005 Sep; 10():2036-44. PubMed ID: 15970476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Causal Connections From Chronic Kidney Disease to Cardiac Fibrosis.
    Hulshoff MS; Rath SK; Xu X; Zeisberg M; Zeisberg EM
    Semin Nephrol; 2018 Nov; 38(6):629-636. PubMed ID: 30413256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of arteriovenous fistulae on the myocardium: the impact of creation and ligation in the transplant era.
    Duque JC; Gomez C; Tabbara M; Alfonso CE; Li X; Vazquez-Padron RI; Asif A; Lenz O; Briones PL; Salman LH
    Semin Dial; 2015; 28(3):305-10. PubMed ID: 25267110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.